Monthly Archives: December 2008

Welcome 2009 – What’s in Store for the Pharmaceutical Industry in the New Year

This is that time off year when we look back and take stock and look forward with resolution to doing things different, as if it is always a matter of choice.  The events of 2008 have been breathtaking and a … Continue reading

Posted in Miscellaney | 1 Comment

New Prostate Cancer Treatment Approved by FDA

Ferring Pharmaceuticals is having a good month and have gotten two significant Holiday gifts, as do patients with prostate cancer.  Last week, the CHMP announced approval of Ferring Pharmaceutical's new treatment for prostate cancer, Degelarix.  Today, the FDA followed suit … Continue reading

Posted in Approval Announcements | 1 Comment

Playing Catch-up

I took last week off for the holidays.  Expecting guests, planning menus and my other regular duties left no time for posting and I suspected, little time for others to be reading.  However, in spite of the holidays, things did … Continue reading

Posted in Approval Announcements, Miscellaney | Comments Off

Weekly Roundup – 12/19/08

The holiday last rush is on.  I'm late with the Weekly Roundup because wrapping gifts took precedence.  Traffic is sadistic.  The weather, unpredictable.  The guests are on the road and on their way here, and there are still menus to … Continue reading

Posted in Weekly Roundup | 1 Comment

FDA Announces New Recommendations on Evaluating Cardiovascular Risk in Drugs Intended to Treat Type 2 Diabetes

Cardiovascular risk associated with diabetes has been a major issue for those developing medications for diabetics.  Yesterday, the FDA issued a press release about new diabetes drug development guidelines that the agency is issuing in relation to the evaluation of … Continue reading

Posted in FDA Policy | Comments Off